CT引导经皮微波消融治疗早期原发性肝癌的临床效果

Abstract
Figure/Table
References (20)
Related Citation (15)

Download: PDF (0 KB) HTML (34 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To study the clinical effect of CT-guided percutaneous microwave ablation (MWA) on treatment of early primary hepatic carcinoma. Methods A total of 86 early primary hepatic carcinoma patients treated in our hospital from January 2013 to July 2016 were selected as research subjects.According to the computer random method,patients were assigned to intervention group (43 cases) and control group (43 cases).The intervention group was treated with CT-guided percutaneous MWA, the control group was treated with conventional transcatheter arterial chemoembolization.The short-term efficacy, long-term efficacy and adverse reactions were compared. Results The total effective rate in intervention group was 81.40%, which was higher than that of control group (55.81%), with statistically significant difference (P＜0.05).The total incidence of adverse reactions between groups showed no statistically significant difference (P＞0.05).One-year survival rate between groups showed no statistically significant difference (P＞0.05).Twoyear and three-year survival rates in intervention group were higher than those of control group, with statistically significant differences (P＜0.05). Conclusion For early primary hepatic carcinoma patients, CT-guided percutaneous MWA has better short-term and long-term efficacy, and lower adverse event rate.

Key words： Percutaneous microwave ablation Primary liver cancer Adverse reactions Malignant tumor Liver cirrhosis

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WU Li-gang
	ZENG Han-qiang▲

Cite this article:

WU Li-gang,ZENG Han-qiang▲. Clinical effect of CT-guided percutaneous microwave ablation on treatment of early primary hepatic carcinoma[J]. 中国当代医药, 2020, 27(15): 52-55.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2020/V27/I15/52

[19]	张秀芳，刘景萍，胡健，等.超声引导下射频与微波消融治疗甲状腺良性结节的比较[J].中国医药导报，2018，15（7）：123-126.
[1]	胡媛媛，肖红兵，孙东旭，等.CT 引导下经皮微波消融治疗周围型肺癌的临床研究[J].临床肺科杂志，2018，23（7）：1210-1213.
[2]	耿利民，寇长元，崔杰，等.CT 引导经皮微波消融联合肝动脉栓塞治疗肝癌的临床疗效[J].现代肿瘤医学，2018，26（9）：1375-1378.
[3]	Henrie AM，Wittstrom K，Delu A，et al.Evaluation of liver biomarkers as prognostic factors for outcomes to Yttrium-90 radioembolization of primary and secondary liver malignancies[J].Cancer Biother Radiopharm，2015，30（7）：305-309.
[4]	廖江荣，王黔宇.CT 引导经皮穿刺微波消融治疗中晚期肺癌的临床分析[J].重庆医学，2018，47（6）：805-808.
[5]	陈嵩，庄文权，郭文波，等.CT 联合超声引导下经皮微波消融治疗尾状叶肝癌的可行性及短期疗效观察[J].影像诊断与介入放射学，2018，27（3）：219-225.
[6]	陈勇.CT 引导下经皮微波消融与常规化疗栓塞治疗肝癌生存情况的随访观察[J].肝脏，2019，24（1）：68-72.
[7]	Fukuhara T，Aikata H，Hyogo H，et al.Efficacy of radiofrequency ablation for initial recurrent hepatocellular carcinoma after curative treatment：Comparison with primary cases[J].Eur J Radiol，2015，84（8）：1540-1545.
[8]	田玉策，聂铭辉.CT 引导下经皮微波消融治疗周围型肺癌的临床研究[J].中国医疗器械信息，2019，25（10）：149-150.
[9]	万欢.超声引导下经皮微波消融与CT 超声引导下肿瘤射频消融治疗原发性肝癌的效果对比[J].临床医药文献电子杂志，2018，5（36）：147-148.
[10]	Li M，Yu X，Liang P，et al.Ultrasound-guided percutaneous microwave ablation for hepatic malignancy adjacent to the gallbladder[J].Int J Hyperthermia，2015，31（6）：579-587.
[11]	贾晓艳.CT 引导下经皮微波消融治疗周围型肺癌的临床效果及价值评价[J].中外医学研究，2019，17（8）：136-138.
[12]	马幸生，张永恒，刘勇恩，等.CT 引导下经皮穿刺微波消融治疗肺癌的临床应用[J].西部医学，2018，30（1）：72-76，80.
[13]	别志欣，李元明，李彬，等.CT 引导下经皮穿刺微波消融治疗老年早期非小细胞肺癌的疗效和安全性[J].中华老年医学杂志，2019，38（7）：722-726.
[14]	Chinnaratha MA，Sathananthan D，Pateria P，et al.High local recurrence of early-stage hepatocellular carcinoma after percutaneous thermal ablation in routine clinical practice[J].Eur J Gastroenterol Hepatol，2015，27（3）：349-354.
[15]	张贤兵，李福华，彭秀兰，等.CT 或彩色多普勒超声引导下经皮穿刺微波消融术治疗肝癌的疗效及对患者血清学指标和免疫功能的影响[J].中国医学前沿杂志（电子版），2018，10（7）：76-79.
[16]	李洪璐，段又佳，陈正光，等.TACE 联合微波消融治疗原发性肝癌特殊部位病灶的跟踪观察[J].临床放射学杂志，2018，37（8）：1369-1373.
[17]	卢钦荣.经导管动脉化疗栓塞术联合微波消融治疗肝癌的临床研究[J].中国当代医药，2019，26（8）：71-73.
[18]	冷燕奎，侯力强，曹智强，等.经皮椎体成形术联合低温等离子消融治疗胸腰椎转移瘤的临床研究[J].中国医药导报，2018，15（6）：71-74.
[20]	章志琼，梁彩红，张小玲.超声引导下微波消融术治疗甲状腺结节围手术期的护理及并发症观察[J].中国医药科学，2019，9（14）：138-140.